Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Scott D. Solomon et al.|New England Journal of Medicine|2019Cited by 6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart FailurePiotr Ponikowski|European Journal of Heart Failure|2016Cited by 5.9k
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008Kenneth Dickstein, Gerasimos Filippatos, John J.V. McMurray et al.|European Journal of Heart Failure|2008Cited by 3.5k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)J.-L. Vachiéry, Kenneth Dickstein, Alain Cohen-Solal et al.|European Heart Journal|2008Cited by 2.7k